Related Experiment Video
Updated: Oct 4, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Long non-coding RNA DLGAP1 antisense RNA 1 accelerates glioma progression via the microRNA-628-5p/DEAD-box helicase
1Department of Neurosurgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, China.
Objectives:
Abnormal expression of long non-coding RNAs (lncRNAs) plays a prominent role in glioma progression. However, the biological function and mechanism of lncRNA DLGAP1 antisense RNA 1 (DLGAP1-AS1) in gliomas are still unknown.
Methods:
The authors assessed DLGAP1-AS1 and miR-628-5p expression in glioma tissues and cell lines using quantitative real-time polymerase chain reaction (qRT-PCR) and evaluated their effects on glioma cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) using the cell counting kit-8 (CCK-8) assay, 5-Ethynyl-2'-deoxyuridine (EdU) assay, Transwell assay, and western blot, respectively. The expression of DEAD-box helicase 59 (DDX59) was quantified using western blotting, and a dual-luciferase reporter gene assay was performed to detect the interaction between DLGAP1-AS1 and miR-628-5p.
Results:
The authors observed increased DLGAP1-AS1 expression in glioma tissues and cell lines with higher WHO grades and shorter survival time. DLGAP1-AS1 promoted the proliferation, migration, invasion, and EMT of glioma cells, while miR-628-5p counteracted these effects. The authors identified DLGAP1-AS1 as a molecular sponge of miR-628-5p in glioma cells as the biological functions of DLGAP1-AS1 are partially mediated via miR-628-5p. In addition, DLGAP1-AS1 upregulated DDX59 expression by inhibiting miR-628-5p expression.
Conclusion:
The DLGAP1-AS1/miR-628-5p/DDX59 axis regulates glioma progression.
Insights
Long non-coding RNA DLGAP1-AS1 promotes glioma progression by sponging miR-628-5p, leading to increased DDX59 expression. This axis is a potential therapeutic target for glioma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Abnormal expression of long non-coding RNAs (lncRNAs) is implicated in glioma progression.
- The specific role of lncRNA DLGAP1 antisense RNA 1 (DLGAP1-AS1) in glioma remains largely uncharacterized.
Purpose of the Study:
- To investigate the biological function and mechanism of DLGAP1-AS1 in glioma.
- To elucidate the regulatory pathway involving DLGAP1-AS1, miR-628-5p, and DDX59 in glioma.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) for gene expression analysis.
- Cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) assays (CCK-8, EdU, Transwell, Western blot).
- Dual-luciferase reporter gene assay to confirm molecular interactions.
Main Results:
- DLGAP1-AS1 expression is upregulated in higher-grade gliomas and correlates with shorter survival.
- DLGAP1-AS1 enhances glioma cell proliferation, migration, invasion, and EMT.
- DLGAP1-AS1 acts as a molecular sponge for miR-628-5p, and this interaction upregulates DEAD-box helicase 59 (DDX59) expression.
Conclusions:
- The DLGAP1-AS1/miR-628-5p/DDX59 axis is a key regulator of glioma progression.
- DLGAP1-AS1 promotes glioma development, partly through the miR-628-5p/DDX59 pathway.
- Targeting this axis may offer a novel therapeutic strategy for glioma.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi
Abnormal Proliferation
